Oncolix, Inc. received OTC Markets' approval to be listed and traded on the OTCQB, effective Dec. 19.
The company had earlier changed its name to Oncolix from Advanced Environmental Petroleum Producers Inc.
With the listing, the company will now able to shift focus towards advancing its potential ovarian cancer treatment Prolanta, said CEO Michael Redman.